BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2013
View Archived Issues
PDL BioPharma acquires royalty rights and milestones for type 2 diabetes products from Depomed
Read More
Researchers at Bristol-Myers Squibb present novel inhibitors of endothelial lipase
Read More
InnoCore and Allergan expand collaboration to develop new medicines for ophthalmic diseases
Read More
Boehringer Ingelheim describes new GPR40 receptor agonists
Read More
Isis Pharmaceuticals patents novel antisense oligonucleotides
Read More
Anacor receives award from Department of Defense for new classes of systemic antibiotics
Read More
Qiagen and Clovis partner to develop companion diagnostic for lung cancer candidate
Read More
MedMira receives further U.S. Army funding to develop tests for transfusion transmitted diseases
Read More
Merck & Co.'s combination regimen for chronic HCV obtains FDA breakthrough therapy designation
Read More
Russian company completes initial clinical trial steps for ABP-560
Read More
Taiho presents TAS-121, a potent and selective EGFR inhibitor
Read More
Gene therapy company Spark Therapeutics spun out of The Children's Hospital of Philadelphia
Read More
Antisense oligonucleotide ISIS-560131 targets the androgen receptor and reduces tumor growth in vivo
Read More
ERP29, IKBKAP gene polymorphisms associated with breast cancer risk and clinical features
Read More
Pharmacokinetics and pharmacodynamics determined for CW-002 in healthy volunteers
Read More
Mouse model created for genetic susceptibility to both dementia and Parkinson's disease
Read More
Daiichi Sankyo discloses new SGLT1/SGLT2 inhibitors
Read More
Merck & Co. and ElexoPharm prepare novel CYP11B2 inhibitors
Read More
New MCH1 receptor antagonists reported by GlaxoSmithKline
Read More
Sucampo and Takeda begin pivotal trial of lubiprostone liquid formulation
Read More
Roche recaps progress of third quarter 2013
Read More
ViiV Healthcare submits NDA for single-tablet HIV regimen
Read More
Enrollment complete in phase III trial of ZS-9 for treatment of hyperkalemia
Read More
DBV Technologies and INSERM form collaboration to develop Viaskin for refractory hemophilia A
Read More
Epirus and Orygen Biotecnologia sign collaboration agreement for biotechnology products in Brazil
Read More